ThoroughCare | $5,000,000 | (Nov 20, 2024)
OneChronos | $32,000,000 | (Nov 20, 2024)
EarthOptics | $24,000,000 | (Nov 20, 2024)
Beaconcure
Israel
- Tel Aviv
- 15/06/2023
- Series B
- $14,000,000
With Beaconcure, pharmaceutical companies and CROs can validate clinical trial data for regulatory approval while cutting submission timelines in half!
By using 'Verify' by Beaconcure, any data inconsistency will be detected automatically during the QC process, reducing handling time and eliminating the possibility of an error-filled submission.
In collaboration with Pfizer, Beaconcure algorithms are designed and trained to support all types of therapeutic areas and study sizes.
With our technology, customers can introduce new treatments earlier to patients, while maintaining IP protection deadlines, accelerating the pipeline so that they can make early revenue and be first to market.
#automation
#machineLearning
#AI
#statisticalanalysis
#regulatorysubmission
#clinicaltrial
- Industry Software Development
- Website https://beaconcure.com/
- LinkedIn https://www.linkedin.com/company/beaconcure/
Related People
Yoran BarFounder
United States -
Boston, Massachusetts
I consider myself a mission-oriented entrepreneur with a solid track record developing & deploying B2B Enterprise data-centric systems. In the last 20 years, I performed senior business executive roles in the Israeli High Technology industry as well as in Europe and the US.
Currently serving as CEO and Co-founder of Beaconcure Inc. and Beaconcure Ltd. a growing startup offering a SaaS solution for clinical data validation. The product serves multinational Pharma and CRO customers world wide.
I also served as the founding Director of 'The HAC', a successful Urban Accelerator based in Israel, where I perform advisory duties supporting the organization and its young entrepreneurs as a pro bono project.
I also operate as Advisory Member for Science Abroad- the organization for Israeli scientists abroad.
I completed my MBA from the University of Den Haag and a BA in Psychology & Communications from the University of South Africa.
RIIG | $3,000,000 | (Nov 20, 2024)
Jimini Health | $8,000,000 | (Nov 20, 2024)
Theranautilus | $1,200,000 | (Nov 19, 2024)
ChapsVision | $90,000,000 | (Nov 19, 2024)
Seen Health | $22,000,000 | (Nov 19, 2024)
GEMESYS | $9,058,380 | (Nov 19, 2024)
SuperAnnotate | $36,000,000 | (Nov 19, 2024)
IonKraft | $3,706,797 | (Nov 19, 2024)